Oncology & Cancer

New pretargeted radioimmunotherapy for colorectal cancer

Investigators at SNM's 58th Annual Meeting are presenting results from a phase 1 clinical trial for a cancer therapy that has the potential to kill colorectal tumors with less destruction of healthy tissue. Further research ...

Oncology & Cancer

High-impact radiopeptide therapy halts neuroendocrine cancer

Research introduced at SNM's 58th Annual Meeting could be a sign of hope for patients with neuroendocrine cancer not responding well to standard therapies. Most radiotherapies use medical isotopes that emit beta radiation. ...

Oncology & Cancer

Oatmeal-labeling ideal for molecular imaging of stomach emptying

Patients undergoing molecular imaging to evaluate their stomach's ability to clear food are going to have an altogether new kind of breakfast. A study presented at SNM's 58th Annual Meeting has confirmed that nuclear medicine ...

page 1 from 2